LDS/Medical Tests/RFC1 (replication factor C subunit 1) Gene Mutation Analysis

RFC1 (replication factor C subunit 1) Gene Mutation Analysis

The RFC1 gene, located on chromosome 4q21, encodes replication factor C subunit 1, a key component of the five-subunit replication factor C (RFC) complex. This complex is a DNA-dependent ATPase essential for both DNA replication and repair. RFC1 plays a central role in loading proliferating cell nuclear antigen (PCNA) onto DNA, forming a clamp that stabilizes DNA polymerases during replication, thereby ensuring replication fidelity. RFC1 is also involved in base excision repair and nucleotide excision repair, where it supports the proper trafficking of repair proteins to DNA lesions.

Pathogenic variants in RFC1, particularly biallelic AAGGG repeat expansions, are strongly associated with CANVAS spectrum disorders, which manifest with cerebellar ataxia, sensory neuropathy, and bilateral vestibular areflexia. RFC1 mutations are also linked to ataxia with oculomotor apraxia type 1, a rare autosomal recessive condition characterized by progressive cerebellar ataxia, impaired voluntary eye movements, and peripheral neuropathy. Detection of RFC1 pathogenic variants is therefore critical for the diagnosis of these neurodegenerative disorders, allowing for accurate clinical classification, family counseling, and supportive management.

  • Confirms the diagnosis of CANVAS spectrum disorders
  • Supports evaluation and monitoring of patients with progressive ataxia and sensory neuropathy
  • Enables carrier detection and risk assessment in families

Positive Result: Presence of RFC1 pathogenic variants, including repeat expansions, consistent with CANVAS or related spectrum disorders.

Negative Result: No pathogenic variants detected; reduces likelihood of RFC1-related disease, though other genetic ataxias should be considered.

Negative (No mutations or pathogenic variants detected)

Targeted repeat-primed Polymerase Chain Reaction (PCR) and variant analysis, Real-time PCR.

Whole blood, EDTA, Saliva, Buccal swab.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7 days
ATXN1 gene mutation analysis, ceruloplasmin, FMR1 gene mutation analysis, TSH, SCA3/SCA7 gene mutation analysis, Atropine 1 gene mutation analysis.
3 to 5 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login